Sutent® 消定®

Sutent® 消定® 是一種美國食品藥品監督管理局認可及獲英國NICE指引推薦的口服標靶藥物1,2。在本港已被關愛基金納入為針對兩種病症的受資助藥物，協助有需要人士踏上治療成功之路3。

參考資料：

  1. Sutent® (sunitinib malate) Prescribing Information. Pfizer Corporation Hong Kong Limited: Version May 2015.
  2. National Institute for Health and Clinical Excellence. NICE technology appraisal guidance 169. March 2009.
  3. Items Supported by the Samaritan Fund and Community Care Fund Medical Assistance Programme. Hong Kong Hospital Authority. Accessed on 6 June 2019. Available at https://www.ha.org.hk/visitor/ha_visitor_index.asp?content_id=208076#.

[PP-CPF-HKG-0070] SEP 2019

Therapeutic Area Sub Category: 
標靶治療 Targeted Therapy